Research Paper Advance Articles
Comprehensive genomic characterization of programmed cell death-related genes to predict drug resistance and prognosis for patients with multiple myeloma
Figure 4. PCD-based risk model construction and validation. (A) Trajectories of each independent variable with lambda and confidence intervals under lambda. (B) Key genes of the prognostic model. (C) Forest plot of key genes of the prognostic model. (D–F) Validation of clinical prognostic models for the MMRF-COMPASS training set cohort, MMRF-COMPASS validation set cohort, and GSE57317 cohort, respectively. They are, from left to right: Risk score, survival time versus survival status and expression of prognostic genes, KM Survival Curve Distribution, and ROC Curve.